Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0QIVML
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Belan-DVA-I030
|
|||||
| Synonyms |
Belan-DVA-I030
Click to Show/Hide
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
~4
|
|||||
|
|
||||||
| Antibody Name |
Belantamab
|
Antibody Info | ||||
| Antigen Name |
Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)
|
Antigen Info | ||||
| Payload Name |
I030
|
Payload Info | ||||
| Therapeutic Target |
IKZF1/3
|
Target Info | ||||
| Linker Name |
MC-DVA-PABC
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines
|
|||||